Connection
Breck Duerkop to CRISPR-Cas Systems
This is a "connection" page, showing publications Breck Duerkop has written about CRISPR-Cas Systems.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.476 |
|
|
|
-
Palacios Araya D, Palmer KL, Duerkop BA. CRISPR-based antimicrobials to obstruct antibiotic-resistant and pathogenic bacteria. PLoS Pathog. 2021 07; 17(7):e1009672.
Score: 0.680
-
Rodrigues M, McBride SW, Hullahalli K, Palmer KL, Duerkop BA. Conjugative Delivery of CRISPR-Cas9 for the Selective Depletion of Antibiotic-Resistant Enterococci. Antimicrob Agents Chemother. 2019 11; 63(11).
Score: 0.604
-
Price VJ, McBride SW, Hullahalli K, Chatterjee A, Duerkop BA, Palmer KL. Enterococcus faecalis CRISPR-Cas Is a Robust Barrier to Conjugative Antibiotic Resistance Dissemination in the Murine Intestine. mSphere. 2019 07 24; 4(4).
Score: 0.148
-
Johnson CN, Sheriff EK, Duerkop BA, Chatterjee A. Let Me Upgrade You: Impact of Mobile Genetic Elements on Enterococcal Adaptation and Evolution. J Bacteriol. 2021 10 12; 203(21):e0017721.
Score: 0.043